论文部分内容阅读
随着互联网技术和信息技术的不断完善和发展,大数据时代已然到来,其运用也已经深入到各个行业、各大领域的发展中,数据本身的价值及其所产生的经济价值也随之增长。在我国药品质量的监管体系中,将大数据运用到监管过程中,能够有效发挥数据的监管优势。运用大数据时代下产生的新技术促进药品质量监管工作,也是顺应大数据时代发展需求的体现,但同时也对我国药品质量监管体系的建设提出了更高的要求。基于此,本文探讨了大数据背景下,分析了我国药品质量监管体系的优化策略和发展趋势。
With the constant improvement and development of Internet technology and information technology, the era of big data has arrived and its application has been deeply penetrated into various industries. In the development of major fields, the value of the data itself and the economic value it generates have also increased . In China’s pharmaceutical quality regulatory system, the use of big data in the regulatory process, can effectively play the regulatory advantages of the data. The use of new technologies generated under the era of big data to promote the regulation of pharmaceutical quality is also an indication of the development needs of the era of big data. However, it also sets higher demands on the construction of China’s pharmaceutical quality supervision system. Based on this, this article explores the background of big data, analyzes the optimization strategy and development trend of China’s pharmaceutical quality supervision system.